A multicenter clinical study with myo-inositol and alpha-lactalbumin in Mexican and Italian PCOS patients.
- 2021-04-01
- Clinical Trial
- European review for medical and pharmacological sciences 25(8)
- I Hernandez Marin
- O Picconi
- A S Laganà
- L Costabile
- V Unfer
- PubMed: 33928619
- DOI: 10.26355/eurrev_202104_25743
- Moderate evidence
- Clinical
The most important results were obtained with insulin, HOMA-index, LH, and androstenedione.
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- 50 mg twice a day